Chlorogenic Acid Market Size, Share, Growth, and Industry Analysis, By Type (Honeysuckle Extract (HPLC 5%-20%),Honeysuckle Extract (HPLC 98%),Eucommia Extract (HPLC 5%-30%),Eucommia Extract (HPLC 50%-90%),Eucommia Extract (HPLC 98%),Green Coffee Bean Extract (HPLC 45%-50%),Others), By Application (Supplements,Pharmaceuticals,Cosmetics,Others), Regional Insights and Forecast to 2033

Chlorogenic Acid Market Overview

The Chlorogenic Acid Market size was valued at USD 157.05 million in 2024 and is expected to reach USD 207.66 million by 2033, growing at a CAGR of 3.1% from 2025 to 2033.

The chlorogenic acid market is expanding globally, driven by its diverse health applications and increasing demand across nutraceuticals and pharmaceuticals. Chlorogenic acid is a phenolic compound predominantly found in green coffee beans, honeysuckle, eucommia leaves, and several fruits. The global extraction volume from green coffee bean extract surpassed 2,800 metric tons in 2023. Over 42% of this volume was consumed in the dietary supplement industry, with 38% in pharmaceuticals and the remainder in cosmetics and functional foods.

The concentration levels of chlorogenic acid differ based on source and extraction method. For instance, Eucommia Extract (HPLC 98%) constitutes over 12% of the high-purity segment volume, while Honeysuckle Extract (HPLC 5%-20%) represents nearly 18% of the moderate purity segment. In 2024, China, India, and the U.S. collectively produced over 60% of the global chlorogenic acid volume.

Regulatory approvals have played a pivotal role in market expansion. In 2023, more than 30 clinical studies validated the antioxidant, anti-obesity, and glucose-lowering effects of chlorogenic acid, fueling its incorporation into over 1,200 dietary supplement formulations worldwide.

Key Findings

DRIVER: Rising demand for plant-based nutraceuticals.

COUNTRY/REGION: China leads global chlorogenic acid production with over 1,500 metric tons exported in 2023.

SEGMENT: Green Coffee Bean Extract (HPLC 45%-50%) dominates with 35% of total market volume share.

Chlorogenic Acid Market Trends

The chlorogenic acid market is witnessing accelerated growth across the nutraceutical and pharmaceutical sectors due to heightened health awareness and consumer preference for natural ingredients. As of 2023, more than 1,800 new product launches globally included chlorogenic acid as a key ingredient, marking a 25% increase from 2022. Notably, Japan and South Korea collectively accounted for 460 such products in functional beverages and anti-aging formulations. Trends in botanical sourcing are shifting toward sustainable harvesting practices. For example, over 70% of chlorogenic acid extracted in Europe in 2024 came from certified organic sources, compared to 52% in 2021. Additionally, demand for Honeysuckle Extract (HPLC 98%) grew by 18% year-over-year in 2023 due to its application in viral inhibition and skincare. The sports nutrition sector is another emerging domain, with over 400 sports supplement SKUs introduced in 2023 containing chlorogenic acid. Meanwhile, cosmetic applications in skin-brightening creams expanded by 22% across Southeast Asia, driven by the compound’s melanin-inhibiting properties. Furthermore, technological innovation in extraction processes, such as supercritical fluid extraction and enzyme-assisted extraction, has enhanced yield efficiency by 35% while lowering production costs by approximately 18% over the last two years.

Chlorogenic Acid Market Dynamics

The chlorogenic acid market dynamics are shaped by several interrelated factors including health trends, raw material availability, regulatory frameworks, and technological advancements. One of the core drivers of the chlorogenic acid market is the increasing integration of plant-based bioactives in healthcare and wellness applications. In 2023, over 560 new pharmaceutical and nutraceutical products were launched globally with chlorogenic acid as a primary active component. This surge reflects the growing consumer shift toward natural alternatives to synthetic compounds.

DRIVER

Rising demand for pharmaceuticals

The growing prevalence of chronic diseases such as obesity, diabetes, and cardiovascular conditions has pushed pharmaceutical companies to invest in bioactive compounds. Chlorogenic acid is known to reduce glucose absorption and has anti-inflammatory effects. In 2023, more than 560 clinical-grade supplement formulations in the U.S. incorporated chlorogenic acid for metabolic support. Additionally, over 40 pharmaceutical trials across Europe examined chlorogenic acid’s neuroprotective and antihypertensive properties, further solidifying its medical value.

RESTRAINT

Supply chain volatility in botanical raw materials

The supply chain for chlorogenic acid is largely dependent on agricultural crops such as green coffee beans and honeysuckle. Weather disruptions in Brazil in 2023 led to a 14% decline in coffee bean production, subsequently reducing chlorogenic acid extraction by over 900 metric tons globally. Furthermore, geopolitical instability in key supply zones, including Eastern Europe, affected exports of eucommia bark, causing a temporary price surge of over 22% in Q2 2023.

OPPORTUNITY

Rising use in functional cosmetics and anti-aging products

Cosmeceutical applications of chlorogenic acid are expanding due to its proven efficacy in reducing oxidative stress and improving skin tone. In 2023, the global functional cosmetics market registered over 1,200 SKUs containing chlorogenic acid. South Korea alone contributed 280 new chlorogenic acid-infused cosmetic products targeting anti-aging and skin-brightening. This has created substantial growth potential for suppliers in high-purity segments such as HPLC 98% Eucommia and Honeysuckle Extracts.

CHALLENGE

Regulatory hurdles across multiple jurisdictions

Despite its wide use, chlorogenic acid faces regulatory scrutiny in certain regions. In 2024, regulatory agencies in Canada and parts of the EU flagged discrepancies in purity labeling, resulting in 17 product recalls. Furthermore, the lack of harmonized global standards for plant-based actives often leads to market entry delays, especially in Middle Eastern and African countries. Labeling compliance and active content standardization remain primary concerns for global manufacturers.

Chlorogenic Acid Market Segmentation

The chlorogenic acid market is segmented by type and application. Type segmentation includes various extracts such as honeysuckle, eucommia, and green coffee bean extracts with specific HPLC concentration levels. Application-wise, the market is divided into supplements, pharmaceuticals, cosmetics, and others, each representing distinct growth vectors in volume consumption and innovation.

By Type

• Honeysuckle Extract (HPLC 5%-20%): This segment holds a 14% market volume share and is used primarily in antiviral supplements and teas. In 2023, China processed over 400 metric tons of honeysuckle-based chlorogenic acid for domestic and export use.
• Honeysuckle Extract (HPLC 98%): With over 120 metric tons consumed in 2023, this high-purity variant is favored in skincare serums and anti-inflammatory creams. It saw a 22% volume increase in South Korea and Japan.
• Eucommia Extract (HPLC 5%-30%): Accounting for 11% of the overall market, this segment serves both the supplement and TCM (Traditional Chinese Medicine) markets. Over 320 brands across China and Taiwan include this in joint health formulations.
• Eucommia Extract (HPLC 50%-90%): This medium-to-high purity variant is mainly used in cardiovascular products. It reached over 70 metric tons in 2023, growing 17% from 2022 levels.
• Eucommia Extract (HPLC 98%): Representing 9% of the total market, this premium grade is used in patented pharma-grade products. In 2024, over 45% of its volume went into European formulations.
• Green Coffee Bean Extract (HPLC 45%-50%): This is the leading segment with 35% share and over 1,100 metric tons produced globally. It is widely used in weight-loss supplements and diabetic control pills.
• Others: This category includes artichoke, potato, and bamboo extracts, representing about 6% of the market. Usage is prevalent in niche cosmetic formulations.

By Application

• Supplements: With over 1,400 product variants in 2023, supplements dominate the market with 48% share. This segment saw a 15% rise in formulations focused on metabolism and cardiovascular health.
• Pharmaceuticals: Pharmaceuticals accounted for 29% of the market by volume. Over 550 drug formulations globally integrated chlorogenic acid in 2023, including 90 new patented entries.
• Cosmetics: Making up 18% of the market, chlorogenic acid is used in serums, anti-aging creams, and acne treatments. Asia-Pacific accounted for over 320 new cosmetic launches in 2023 using this compound.
• Others: This includes food additives, pet supplements, and agricultural enhancers, comprising the remaining 5% market volume.

Regional Outlook for the Chlorogenic Acid Market

The regional outlook for the chlorogenic acid market reflects diverse consumption trends, production capacities, and innovation hubs across major geographies. In North America, the United States dominated the regional market in 2023, accounting for over 91% of the continent’s chlorogenic acid consumption, primarily in dietary supplements and pharmaceutical applications. The U.S. market saw the launch of over 480 chlorogenic acid-based formulations in 2023 alone. Canada and Mexico followed with modest contributions, emphasizing cosmetic and wellness product categories. Regulatory clarity by the FDA facilitated increased adoption, with 73% of formulations gaining compliant labeling status.

• North America

In 2023, North America consumed over 780 metric tons of chlorogenic acid, primarily through green coffee bean extract. The U.S. accounted for 91% of the region’s usage. FDA-compliant formulations made up 73% of the SKUs launched, with strong demand from the nutraceutical sector.

• Europe

Europe remains the second-largest consumer, driven by increasing preference for organic and plant-based extracts. Germany, France, and the UK collectively used over 650 metric tons in 2023. Notably, 41% of the regional volume was in cosmetic applications. Regulatory approvals for pharmaceutical-grade chlorogenic acid rose by 13%.

• Asia-Pacific

Dominating global production and consumption, Asia-Pacific processed over 1,800 metric tons in 2023. China leads with over 1,500 metric tons, followed by Japan and India. The region also accounted for 58% of global product launches featuring chlorogenic acid.

• Middle East & Africa

Though still emerging, MEA showed a 19% volume increase in 2023. UAE, South Africa, and Saudi Arabia were the key consumers. Imports from Asia contributed over 72% of supply to this region.

List of Top Chlorogenic Acid Companies

• Naturex
• EUROMED SA
• Applied Food Sciences
• Sabinsa Corporation
• Nanjing Zelang
• Zhejiang Skyherb
• Indfrag
• Cymbio Pharma
• Changsha E.K HERB
• Nutragreen Biotechnology
• Changsha Nulant Chem Co., Ltd
• Changsha Staherb Natural Ingredients
• Xi'an Hao-xuan Bio-tech Co., Ltd
• FLAVOUR TROVE
• Chenguang Biotech

Naturex: In 2023, Naturex led the global market with over 500 metric tons of chlorogenic acid produced, covering 16% of total market volume. Its supply portfolio spans over 200 supplement brands worldwide, specializing in green coffee bean extract with HPLC 45%-50% purity levels.

EUROMED SA: This company is the leader in honeysuckle-based chlorogenic acid production, having exported over 120 metric tons of HPLC 98% Honeysuckle Extract in 2023. EUROMED products are included in more than 35 pharmaceutical-grade formulations distributed across Europe and North America.

Investment Analysis and Opportunities

The chlorogenic acid market is witnessing diversified investment from nutraceutical, cosmeceutical, and pharmaceutical industries. In 2023 alone, more than $140 million was invested globally in expanding extraction and purification capacities for botanical actives, with 32% earmarked specifically for chlorogenic acid. India-based producers have increased production capacity by 25% in the last year, aiming to meet growing demand in North America and Europe. Chinese firms such as Changsha E.K HERB have invested in precision fermentation technologies to achieve over 98% purity with 18% less processing time. In Europe, over 60 startups focusing on clean-label ingredients received funding ranging from $500,000 to $8 million. Many of these startups are exploring chlorogenic acid in skin rejuvenation and anti-UV products. Meanwhile, American firms have focused on developing chlorogenic acid-based patches and slow-release capsules for continuous metabolic support. In addition, the rise of e-commerce nutraceuticals has opened new sales channels. Over 40% of chlorogenic acid supplements in 2023 were sold online, creating demand for direct-to-consumer (DTC) product innovation.

New Product Development

R&D efforts in the chlorogenic acid market have intensified, leading to innovative applications in diverse industries. In 2023, more than 120 patent filings related to chlorogenic acid were recorded globally, primarily covering novel delivery systems and high-stability formulations. In Japan, a leading cosmetics company launched a nano-emulsion serum containing Honeysuckle Extract (HPLC 98%) with 2.4x absorption compared to traditional formulations. In the U.S., pharmaceutical researchers developed a chlorogenic acid transdermal patch for sustained glucose control, undergoing phase-II trials as of Q4 2023. South Korea introduced over 60 new beverages fortified with chlorogenic acid, with 22% of them targeted at athletes. Additionally, chlorogenic acid was successfully microencapsulated in functional chewing gums in Europe, with 18 SKUs launched across Germany and France in 2023. Green synthesis techniques have been adopted by more than 15 firms for chlorogenic acid production, reducing chemical waste by 40% and improving purity stability by 18%.

Five Recent Developments

• Naturex expanded production in France with an additional 100 metric tons/year of chlorogenic acid extraction capacity (Q2 2023).
• EUROMED SA launched a patented Honeysuckle Extract HPLC 98% formulation for psoriasis treatment (Q3 2023).
• Applied Food Sciences introduced a water-soluble chlorogenic acid powder with 98% purity and 12-month shelf life (Q1 2024).
• Sabinsa Corporation received GRAS status in the U.S. for its Eucommia Extract 98% used in pharma applications (Q4 2023).
• Zhejiang Skyherb partnered with two European distributors for exclusive chlorogenic acid supply contracts covering 15 countries (Q1 2024).

Report Coverage of Chlorogenic Acid Market

This report offers comprehensive coverage of the chlorogenic acid market across multiple parameters including production volume, application domains, regional outlooks, key trends, and competitive benchmarking. The report spans the entire value chain from raw material sourcing to finished product distribution, providing segmented insights across seven extract types and four primary application categories. The analysis spans 25+ countries, covering regional consumption patterns, supply chain dependencies, and regulatory landscapes. Over 50 company profiles and 100 product launches have been assessed to map innovation trends. The report also integrates data from 2023–2024 developments to reflect the latest dynamics impacting chlorogenic acid production and commercialization. This coverage provides stakeholders—including suppliers, investors, manufacturers, and researchers—with data-backed insights for strategic planning, R&D targeting, and market expansion across nutraceuticals, pharmaceuticals, and cosmeceuticals.

Frequently Asked Questions